Dr. Terry C. Lin, DO

Dr. Lin practices at Silicon Valley Surgery Center - HOPD in Los Gatos, California.

Dr. Lin's NPI, 1134258213, was assigned on March 5, 2007. Dr. Lin graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1992. Dr. Lin's California license number on file is A65180.

Dr. Lin's primary practice is Silicon Valley Surgery Center - HOPD, at 14601 S Bascom Ave, Los Gatos, CA 95032.

Dr. Lin's primary practice is Silicon Valley Surgery Center - HOPD in Los Gatos, California. Dr. Lin is also affiliated with Good Samaritan Hospital. Dmand AI also links Dr. Lin to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lin is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Lin's licenses on file in 2 states: California and Colorado.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Lin treats.

CMS data shows 1,250 Medicare services from Dr. Lin across 12 procedure codes in 2024, for 509 Medicare patients. Medicare paid $127,884 for them.

CMS counts 509 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 217 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 68, with 48% women.

In 2024, Dr. Lin wrote 1,248 Medicare Part D claims for 439 patients. 89% of them were for generic drugs. CMS names the drug for 1,091 of them, across 15 drugs with 11 or more claims each, at $59,294 in total drug cost. In 2023, CMS named 1,021 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 29 out of 100 for Dr. Lin for performance year 2024, reported individually. CMS counts 164 procedures of colonoscopy by Dr. Lin, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Lin, published from 2018 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Circadian Rhythm, Fasting and Mice, Inbred C57BL. Dr. Lin has published most often in Cell Metab. Dr. Lin's most frequent co-authors are Nehal N. Mehta, MD, Ricardo A. Ramos, MD and Joseph L. Witztum, MD.

Dr. Lin graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 1992.

Dr. Lin is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.